Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-04

Clinical Trial Update: Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing long-term safety and effectiveness of Dysport in adults with cervical dystonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2017-05-04